Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer

Details for Australian Patent Application No. 2003252976 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen, Robert

Agent Davies Collison Cave

Pub. Number AU-B-2003252976

PCT Number PCT/GB03/03390

PCT Pub. Number WO2004/014426

Priority 0218526.2 09.08.02 GB

Filing date 5 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 3 May 2007

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 0218526.2 09.08.02 GB

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003252976

3 May 2007 Application Accepted

  Published as AU-B-2003252976

30 August 2007 Standard Patent Sealed

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003252977-An analgesic agent for newborn or fetal subjects

2003252975-LIGHTING INSTALLATION